Nature Communications (Nov 2017)
Multicomponent mapping of boron chemotypes furnishes selective enzyme inhibitors
Abstract
Heteroatom-rich organoboron compounds are promising modulators of enzyme activity. Here, the authors report a library of aminocyanoboronates as serine hydrolases inhibitors with the most potent compound showing in vivo and in vitro nanomolar activity and high selectivity towards human ABHD3 hydrolase.